Opioid Epidemic – One America News Network

STAMFORD, CT - APRIL 2: Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Connecticut. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, are facing hundreds of lawsuits across the country for the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans over the past 20 years. (Photo by Drew Angerer/Getty Images)

Supreme Court Blocks Purdue Pharma Bankruptcy Opioid Settlement

The Supreme Court blocked the historic opioid settlement, involving opioid maker Purdue Pharma on Thursday, stating that the settlement inappropriately included legal protections for the Sackler family.

Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017. REUTERS/Bryan Woolston/File Photo

Drugmaker Amneal agrees to $270 million U.S. opioid settlement

Amneal said on Friday it had reached a deal valued at more than $270 million to resolve claims it helped fuel the deadly U.S. opioid epidemic.

US-HEALTH-OPIOID-OXYCODON-ILLUSTRATION This illustration image shows tablets of opioid painkiller Oxycodone delivered on medical prescription taken on September 18, 2019 in Washington,DC. - Millions of Americans sank into addiction after using potent opioid painkillers that the companies churned out and doctors freely prescribed over the past two decades. Well over 400,000 people died of opioid overdoses in that period, while the companies involved raked in billions of dollars in profits. And while the flood of prescription opioids into the black market has now been curtailed, addicts are turning to heroin and highly potent fentanyl to compensate, where the risk of overdose and death is even higher. (Photo by Eric BARADAT / AFP) (Photo by ERIC BARADAT/AFP via Getty Images)

Publicis Health Agrees To $350M Settlement Over Role In America’s Opioid Epidemic

Attorney General (AG) Andrea Joy Campbell announced a $350 million national settlement with Publicis Health in order to settle claims that the company helped OxyContin maker Purdue Pharma fuel the deadly opioid epidemic in the United States.

In this November 30, 2021 photo, syringes and other medical equipment are shown during the media tour of their supervised drug injection site OnPoint, in New York. - New York City has opened two supervised drug injection sites in the Harlem and Washington Heights neighborhoods in an effort to address the increase in overdose deaths. Operated by OnPoint NYC, a consortium of two nonprofit social welfare organizations, these centers are the first to be officially licensed in the United States. They offer opioid and other drug users a variety of services, including addiction treatment. (Photo by Yuki IWAMURA / AFP) (Photo by YUKI IWAMURA/AFP via Getty Images)

Dr. Discusses Fight Against Fentanyl as Opioid Crisis Continues

Fentanyl continues to hold America in its grip. One America’s Stephanie Myers speaks with Dr. Paul Christo